BridgeBio Pharma Inc.

11/16/2026 | Press release | Distributed by Public on 11/16/2026 13:04

Acoramidis Reduces Days Lost to Death and/or Cardiovascular-Related Hospitalization, Preserving Time Alive Outside the Hospital in Participants With ATTR-CM: Results From[...]

BridgeBio Pharma Inc. published this content on November 16, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 16, 2026 at 19:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]